Computer-Aided Drug Design Using the Fragment Molecular Orbital Method: Current Status and Future Applications for SBDD

Chem Pharm Bull (Tokyo). 2024;72(9):781-786. doi: 10.1248/cpb.c23-00839.

Abstract

Owing to the increasing use of computers, computer-aided drug design (CADD) has become an essential component of drug discovery research. In structure-based drug design (SBDD), including inhibitor design and in silico screening of drug target molecules, concordance with wet experimental data is important to provide insights on unique perspectives derived from calculations. Fragment molecular orbital (FMO) method is a quantum chemical method that facilitates precise energy calculations. Fragmentation method makes it possible to apply the quantum chemical method to biological macromolecules for energy calculation based on the electron behavior. Furthermore, interaction energies calculated on a residue-by-residue basis via fragmentation aid in the analysis of interactions between the target and ligand molecule residues and molecular design. In this review, we outline the recent developments in SBDD and FMO methods and highlight the prospects of developing machine learning approaches for large computational data using the FMO method.

Keywords: computer-aided drug design; fragment molecular orbital database (FMODB); fragment molecular orbital method; machine learning; structure-based drug design.

Publication types

  • Review

MeSH terms

  • Computer-Aided Design*
  • Drug Design*
  • Humans
  • Ligands
  • Machine Learning
  • Molecular Structure
  • Quantum Theory*

Substances

  • Ligands